Effects of simvastatin on angiogenic growth factors released at the site of microvascular injury [4]

Thrombosis and Haemostasis

Volumn 95, Issue 6, 2006, Pages 1045-1047

  Undas, Anetta ^a   Celińska Lowenhoff, Magdalena ^a   Stepień, Ewa ^a   Nizankowski, Rafal ^a   Tracz, Wieslawa ^a   Szczeklik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; FENOFIBRATE; GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPANTHYL SUPRA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLATELET DERIVED GROWTH FACTOR BB; SIMVASTATIN; TRIACYLGLYCEROL; VASCULOTROPIN;

ATHEROSCLEROSIS; BLOOD SAMPLING; BLOOD VESSEL INJURY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; VENOUS BLOOD;

ADULT; AGED; ANGIOGENIC PROTEINS; ANTICHOLESTEREMIC AGENTS; BLEEDING TIME; CD40 LIGAND; FEMALE; HEMOSTATIC TECHNIQUES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; PROCETOFEN; SIMVASTATIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745319092     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-01-0022     Document Type: Letter

References (17)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
2. Celletti FL, Waugh JM, Amabile PG, et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001; 7: 425-9.
3. Weis M, Heeschen C, Glassford AJ, et al. Statins have biphasic effects on angiogenesis. Circulation 2002; 105: 739-45.
4. Alber HF, Dulak J, Frick M, et al. Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease. J Am Coll Cardiol 2002; 39: 1951-5.
5. Blann AD, Belgore FM, Constans J, et al. Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. Am J Cardiol 2001; 87: 1160-3.
6. Kranz A, Rau C, Kochs M, et al. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction: evidence for its origin and functional significance. J Moll Cell Cardiol 2000; 32: 65-72.
7. Mohle R, Green D, Moore MA, et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakariocytes and platelets. Proc Natl Acad Sci USA 1997; 94: 663-8.
8. Weltermann A, Wolzt M, Petersmann K, et al. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo. Arterioscler Thromb Vasc Biol 1999; 19: 1757-60.
9. Heldin CH, Westermark B. Mechanism of action and in vivo role platelet-derived growth factor. Physiol Rev 1999; 79: 1283-316.
10. Undas A, Celinska-Lowenhoff M, Domagala TB, et al. Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia. Thromb Haemost 2005; 94: 193-9.
11. Undas A, Brummel KE, Musial J, et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation 2001; 103: 2248-53.
12. Undas A, Celinska-Löwenhoff M, Kaczor M, et al. New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thromb Haemost 2004; 91: 1065-77.
13. Gajdos M, Mongiellova V, Huttova D, et al. Ciprofibrate increases plasma concentration of platelet-derived growth factor AB in patients with advanced atherosclerosis and hyperlipidemia independently of its hypolipidemic effects. J Cardiovasc Pharmacol 2001; 38: 651-6.
14. Anand SX, Viles-Gonzalez JF, Badimon JJ, et al. Membrane-associated CD40L and sCD40L in atherothrombotic disease. Thromb Haemost 2003; 90: 377-84.
15. Puccetti L, Pasqui AL, Pastorelli M, et al. Time-dependent effect of statins on platelet function in hypercholesterolaemia. Eur J Clin Invest 2002; 32: 901-8.
16. Casani L, Sanchez-Gomez S, Vilahur G, et al. Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering. Thromb Haemost 2005; 94: 1035-41.
17. Heeschen C, Dimmeler S, Hamm CW, et al. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation 2003; 107: 524-30.